Manufacturing and Facilities eBook
Read the article: A Look at Supply Chain for Scale Up
Read the eBook: BioPharm International’s Manufacturing and Facilities 2023 eBook
CONTINUE TO SITE
OR WAIT null SECS
Advertisement
- About Us
- Advertise
- Editorial Information
- Contact Us
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and BioPharm International. All rights reserved.
A Look at Supply Chain for Scale Up
Published on:
Feliza Mirasol
BioPharm International, Manufacturing and Facilities, November 2023 eBook, Volume 2023 eBook, Issue 4
Pages: 12
Taking a brief status check on the biologics supply chain and any impact on scale up operations.
In speaking with Suzanne Aldington, senior principal scientist, Downstream Processing, Biologics, and Lucas Lin, senior principal scientist, Global Process Development Implementation, Biologics, both at Lonza, BioPharm International® took a pulse on the supply chain lifeline for biologics in the post-pandemic setting. Discussion revolved around any impact the current state of the supply chain may be imparting on scale-up activities in downstream bioprocessing.
Read this article in BioPharm International®’s Manufacturing and Facilities 2023 eBook.
Advertisement
About the author
Feliza Mirasol is the science editor for BioPharm International.
Article details
BioPharm International
eBook: Manufacturing and Facilities 2023
November 2023
Page: 12
Citation
When referring to this article, please cite it as Mirasol, F. A Look at Supply Chain for Scale Up. BioPharm International’s Manufacturing and Facilities 2023 eBook. November 2023.
